Postzygotic mosaicism in cerebral cavernous malformation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31446422.
- Also identified by DOI 10.1136/jmedgenet-2019-106182 and PMC identifier 7042965.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cerebral cavernous malformations (CCMs) can cause severe neurological morbidity but our understanding of the mechanisms that drive CCM formation and growth is still incomplete. Recent experimental data suggest that dysfunctional CCM3-deficient endothelial cell clones form cavernous lesions in conjunction with normal endothelial cells. In this study, we addressed the question whether endothelial cell mosaicism can be found in human cavernous tissue of <i>CCM1</i> germline mutation carriers. Bringing together single-molecule molecular inversion probes in an ultra-sensitive sequencing approach with immunostaining to visualise the lack of CCM1 protein at single cell resolution, we identified a novel late postzygotic <i>CCM1</i> loss-of-function variant in the cavernous tissue of a de novo <i>CCM1</i> germline mutation carrier. The extended unilateral CCM had been located in the right central sulcus causing progressive proximal paresis of the left arm at the age of 15 years. Immunohistochemical analyses revealed that individual caverns are lined by both heterozygous (<i>CCM1<sup>+/-</sup></i> ) and compound heterozygous (<i>CCM1<sup>-/-</sup></i> ) endothelial cells. We here demonstrate endothelial cell mosaicism within single caverns of human CCM tissue. In line with recent in vitro data on CCM1-deficient endothelial cells, our results provide further evidence for clonal evolution in human CCM1 pathogenesis.
Medical subject headings
- Genetic Predisposition to Disease
- Hemangioma, Cavernous, Central Nervous System
- KRIT1 Protein
- Mosaicism